The Journal of Allergy and Clinical Immunology
Volume 119, Issue 1 , Pages 199-205 , January 2007

Egg oral immunotherapy in nonanaphylactic children with egg allergy

  • Ariana D. Buchanan, MD

      Affiliations

    • From the Department of Pediatrics, Duke University Medical Center, Durham
    • These authors contributed equally to this work.
    • ,
  • Todd D. Green, MD

      Affiliations

    • From the Department of Pediatrics, Duke University Medical Center, Durham
    • These authors contributed equally to this work.
    • ,
  • Stacie M. Jones, MD

      Affiliations

    • Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock
    • Arkansas Children's Hospital, Little Rock
    • ,
  • Amy M. Scurlock, MD

      Affiliations

    • Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock
    • Arkansas Children's Hospital, Little Rock
    • ,
  • Lynn Christie, RD

      Affiliations

    • Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock
    • Arkansas Children's Hospital, Little Rock
    • ,
  • Karen A. Althage, RN

      Affiliations

    • Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock
    • Arkansas Children's Hospital, Little Rock
    • ,
  • Pamela H. Steele, CPNP

      Affiliations

    • From the Department of Pediatrics, Duke University Medical Center, Durham
    • ,
  • Laurent Pons, PhD

      Affiliations

    • From the Department of Pediatrics, Duke University Medical Center, Durham
    • ,
  • Rick M. Helm, PhD

      Affiliations

    • Department of Microbiology, University of Arkansas for Medical Sciences, Little Rock
    • ,
  • Laurie A. Lee, MD

      Affiliations

    • From the Department of Pediatrics, Duke University Medical Center, Durham
    • ,
  • A. Wesley Burks, MD

      Affiliations

    • From the Department of Pediatrics, Duke University Medical Center, Durham
    • Corresponding Author InformationReprint requests: A. Wesley Burks, MD, Duke University Medical Center, Box 2644, Durham, NC 27710.

Received 11 May 2006 ,Revised 7 September 2006 ,Accepted 11 September 2006.

References 

  1. Sicherer SH, Sampson HA. Food allergy. J Allergy Clin Immunol. 2006;117:S470–S475
  2. Sampson HA. Food allergy. Part 2: diagnosis and management. J Allergy Clin Immunol. 1999;103:981–989
  3. Cohen BL, Noone S, Munoz-Furlong A, Sicherer SH. Development of a questionnaire to measure quality of life in families with a child with food allergy. J Allergy Clin Immunol. 2004;114:1159–1163
  4. Primeau MN, Kagan R, Joseph L, Lim H, Dufresne C, Duffy C, et al. The psychological burden of peanut allergy as perceived by adults with peanut allergy and the parents of peanut-allergic children. Clin Exp Allergy. 2000;30:1135–1143
  5. Sicherer SH, Noone SA, Munoz-Furlong A. The impact of childhood food allergy on quality of life. Ann Allergy Asthma Immunol. 2001;87:461–464
  6. Sampson HA. Anaphylaxis and emergency treatment. Pediatrics. 2003;111(suppl):1601–1608
  7. Varney VA, Gaga M, Frew AJ, Aber VR, Kay AB, Durham SR. Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs. BMJ. 1991;302:265–269
  8. Durham SR, Walker SM, Varga EM, Jacobson MR, O'Brien F, Noble W, et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med. 1999;341:468–475
  9. Abramson M, Puy R, Weiner J. Immunotherapy in asthma: an updated systematic review. Allergy. 1999;54:1022–1041
  10. Oppenheimer JJ, Nelson HS, Bock SA, Christensen F, Leung DY. Treatment of peanut allergy with rush immunotherapy. J Allergy Clin Immunol. 1992;90:256–262
  11. Nelson HS, Lahr J, Rule R, Bock A, Leung D. Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract. J Allergy Clin Immunol. 1997;99:744–751
  12. Burks AW. Classic specific immunotherapy and new perspectives in specific immunotherapy for food allergy. Allergy. 2003;67:121–124
  13. Eigenmann PA. Future therapeutic options in food allergy. Allergy. 2003;58:1217–1223
  14. Chehade M, Mayer L. Oral tolerance and its relation to food hypersensitivities. J Allergy Clin Immunol. 2005;115:3–12
  15. Patriarca G, Nucera E, Roncallo C, Pollastrini E, Bartolozzi F, De Pasquale T, et al. Oral desensitizing treatment in food allergy: clinical and immunological results. Aliment Pharmacol Ther. 2003;17:459–465
  16. Meglio P, Bartone E, Plantamura M, Arabito E, Giampietro PG. A protocol for oral desensitization in children with IgE-mediated cow's milk allergy. Allergy. 2004;59:980–987
  17. Sampson HA, Ho DG. Relationship between food-specific IgE concentrations and the risk of positive food challenges in children and adolescents. J Allergy Clin Immunol. 1997;100:444–451
  18. Sicherer SH, Burks AW, Sampson HA. Clinical features of acute allergic reactions to peanut and tree nuts in children. Pediatrics. 1998;102:e6
  19. Joshi P, Mofidi S, Sicherer SH. Interpretation of commercial food ingredient labels by parents of food-allergic children. J Allergy Clin Immunol. 2002;109:1019–1021
  20. Vierk K, Falci K, Wolyniak C, Klontz KC. Recalls of foods containing undeclared allergens reported to the US Food and Drug Administration, fiscal year 1999. J Allergy Clin Immunol. 2002;109:1022–1026
  21. Altschul AS, Scherrer DL, Munoz-Furlong A, Sicherer SH. Manufacturing and labeling issues for commercial products: relevance to food allergy. J Allergy Clin Immunol. 2001;108:468
  22. Bollinger ME, Dahlquist LM, Mudd K, Sonntag C, Dillinger L, McKenna K. The impact of food allergy on the daily activities of children and their families. Ann Allergy Asthma Immunol. 2006;96:415–421
  23. Gruchalla RS. Acute drug desensitization. Clin Exp Allergy. 1998;28(suppl 4):63–64
  24. Frew AJ. Immunotherapy of allergic disease. J Allergy Clin Immunol. 2003;111(suppl):S712–S719
  25. Lehrer SB, Wild LG, Bost KL, Sorensen RU. Immunotherapy for food allergies. Past, present, future. Clin Rev Allergy Immunol. 1999;17:361–381
  26. Scurlock AM, Burks AW. Peanut allergenicity. Ann Allergy Asthma Immunol. 2004;93(suppl 3):S12–S18
  27. Sampson HA, Srivastava K, Li XM, Burks AW. New perspectives for the treatment of food allergy (peanut). Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M. 2003;94:236–244
  28. Li XM, Sampson HA. Novel approaches to immunotherapy for food allergy. Clin Allergy Immunol. 2004;18:663–679
  29. Leung DY, Sampson HA, Yunginger JW, Burks AW, Schneider LC, Wortel CH, et al. Effect of anti-IgE therapy in patients with peanut allergy. N Engl J Med. 2003;348:986–993
  30. Hamelmann E, Rolinck-Werninghaus C, Wahn U. Is there a role for anti-IgE in combination with specific allergen immunotherapy?. Curr Opin Allergy Clin Immunol. 2003;3:501–510
  31. Canonica GW, Passalacqua G. Noninjection routes for immunotherapy. J Allergy Clin Immunol. 2003;111:437–448
  32. Bousquet J, Lockey R, Malling HJ. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol. 1998;102:558–562
  33. Malling HJ, Abreu-Nogueira J, Alvarez-Cuesta E, Bjorksten B, Bousquet J, Caillot D, et al. Local immunotherapy. Allergy. 1998;53:933–944
  34. Wilson DR, Torres LI, Durham SR. Sublingual immunotherapy for allergic rhinitis. Cochrane Database Syst Rev. 2003;(2):CD002893
  35. Boyano-Martinez T, Garcia-Ara C, Diaz-Pena JM, Martin-Esteban M. Prediction of tolerance on the basis of quantification of egg white-specific IgE antibodies in children with egg allergy. J Allergy Clin Immunol. 2002;110:304–309

 Supported by the University of Arkansas for Medical Sciences Chancellor's Research Fund and the Arkansas Children's Hospital Pediatric Clinical Research Unit, as well as the Duke General Clinical Research Center, grant 5M01-RR-000030-45, National Center for Research Resources, Clinical Research Centers Program, and National Institutes of Health.Disclosure of potential conflict of interest: S. M. Jones has received grant support from the National Institutes of Health, the National Institute of Allergy and Infectious Diseases, Dyax, Mead Johnson, Merck, GlaxoSmithKline, Novartis, Genentech, AstraZeneca, and Aventis. L Christie has consulting arrangements with the Food Allergy and Anaphylaxis Network. P. H. Steele is on the speakers' bureau for Sepracor Pharmaceuticals. A. W. Burks has consultant arrangements with Genentech; owns stock in Seer, Inc; has patent licensing arrangements on peanut allergens and Methods, Isolated, and Purified Ara H2 antigen for producing mAbs for Ara h 2; and has received grant support from NCRR and the National Institutes of Health; and is on the speakers' bureau for Novartis and Dey. The rest of the authors have declared that they have no conflict of interest.

PII: S0091-6749(06)01938-5

doi: 10.1016/j.jaci.2006.09.016

The Journal of Allergy and Clinical Immunology
Volume 119, Issue 1 , Pages 199-205 , January 2007

Article Tools

* Image Usage & Resolution